關於 cookie 的說明

本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗,我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示,便表示您已接受我們的網站使用條款。

Sisram Medical to Report FY 2024 Financial Results on March 19 and Hold a Conference Call on March 20

文章來源 : PR Newswire 美通社 發表時間 : 瀏覽次數 : 257 加入收藏 :

FY 2024 conference call to be held on March 20, at 8:00 a.m. Eastern Time

HONG KONG, March 13, 2025 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries referred as the "Group"), a global consumer wellness group featuring a first-of-its-kind synergistic ecosystem of business building blocks and consumer-focused brands, emphasizing on energy-based devices and injectables, alongside other complementary offerings, today announced that it expects to release its financial results for FY 2024, ended December 31, on Wednesday, March 19, 2024.

Sisram's management team will host a conference call to discuss the financial results on Thursday, March 20, 2024, at 8:00 a.m. Eastern Time.

Speakers will include Mr. Liu Yi, Sisram's Chairman, Mr. Lior Dayan, Sisram's Chief Executive Officer, Mr. Jiahong LI, Sisram's CFO, Mr. Doron Yannai, Alma's CFO, and Ms. Qianli Fang, Sisram's Secretary of the Board.  Following the prepared remarks, management will be available for a question-and-answer session.

please register in advance for the webinar using the following link: https://cicc.zoom.us/webinar/register/WN_tpYp8hdUQvOgnjIM4JHI6g

After registering, you will receive a confirmation email with instructions for joining the webinar.

The conference call will begin at:
8:00 a.m. Eastern Time
5:00 a.m. Pacific Time
2:00 p.m. Israel Time

A replay will also be available on Sisram Medical's  IR Events & Presentations page.

About Sisram Medical Ltd 

Sisram Medical Ltd (1696.HK) is a global consumer wellness group, featuring a first-of-its-kind synergistic ecosystem of business building blocks and consumer-focused branding, emphasizing on energy-based devices and injectables, alongside other complementary offerings. The Company is majority owned by Fosun Pharma, one of China's leading healthcare groups. On September 19, 2017, Sisram Medical went public on the Main Board of the Hong Kong Exchange.

Sisram Medical – Enhancing Quality of Life
http://www.sisram-medical.com 

 

以上新聞投稿內容由 PR Newswire 美通社 全權自負責任,若有涉及任何違反法令、違反本網站會員條款、有侵害第三人權益之虞,將一概由 PR Newswire 美通社 承擔法律及損害賠償之責任,與台灣產經新聞網無關。

Tags :
2025 年 4 月 2 日 (星期三) 農曆三月初五日
首 頁 我的收藏 搜 尋 新聞發佈